FOREVR Peds VR Pilot

Children's Hospital Medical Center, Cincinnati111 enrolled

Overview

To determine the feasibility and acceptability of using immersive virtual reality technologies to impact clinical outcomes (e.g., pain and anxiety) and medication utilization (e.g., narcotics) in pediatric patients with acute and chronic pain.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

111

Conditions

Pain, Postoperative Pain Anxiety

Interventions

VR - DistractionOTHER

Participants will be instructed to use any application.

VR - BiofeedbackOTHER

Participants will be instructed to use the Mindful Aurora application.

Eligibility

Sex: ALLMin age: 7 YearsMax age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Ages 7to 21 years * Able to read, understand, and speak English * Patients in the immediate postoperative period with significant pain being followed by the Acute Pain Service (acute postoperative pain cohort); patients presenting in Same Day Surgery for peripheral IV placement or patients in the CBDI clinic presenting for peripheral IV placement or Port accessing (vascular access cohort); or patients admitted to CCHMC on the Medical Pain Service (chronic pain cohort), or sickle cell patients not on the MPS list. * Patients who have undergone bone marrow transplantation or receiving chemotherapy experiencing pain from mucositis Exclusion Criteria: * Outside the age range (\< 7 or \> 21 years) * History of developmental delays, uncontrolled psychiatric conditions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting) * History of vertigo, dizziness, and/or seizure disorder * Conditions that would preclude the application of the VR glasses, such as surgeries of the head and neck

Locations (1)

Cincinnati Childrens Hospital Medical Center

Cincinnati, Ohio, United States

Outcomes

Primary Outcomes

Effect of VR-distraction on anxiety

Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety

Time frame: Before 10 minute VR session.

Effect of VR-Distraction on anxiety

Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety

Time frame: Immediately after 10 minute VR session.

Effect of VR-Distraction on anxiety

Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety

Time frame: 15 minutes after 10 minute VR session.

Effect of VR-Distraction on anxiety

Anxiety scores will be collected. Anxiety will be rated using a numerical rating scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety

Time frame: 30 minutes after 10 minute VR session.

Effect of VR-Distraction on pain

Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain

Time frame: Before 10 minute VR session.

Effect of VR-Distraction on pain

Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain

Time frame: Immediately after 10 minute VR session.

Effect of VR-Distraction on pain

Pain scores will be collected. Pain will be rated using a numerical rating scale. Pain will be rated from 0 - 10. 0 meaning no pain 10 being severe pain

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

FOREVR Peds VR Pilot

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes